Skip to main content
Equibles

FMS · Fresenius Medical Care AG

Track FMS — free

Use FMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.25 -0.01 (-0.04%) At close · Oct 2
Rebalance outlook locked
Market Cap
$12.08B
Shares
532.22M
Volume · Oct 2 478.55K Avg daily vol (3M) 693.09K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$22.25 Open$22.14 Day$22.09–22.29 52W close$20.19–27.41 Avg vol 30d701K Short int2.8M · 0.5% float · 4.7d Short vol52% Last earningsNov 3, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Nov 3, 2026 Scheduled · in 4 wks
Q4 2025 earnings call transcript
call held Feb 24, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$22.66B
Trailing 12 months
Net income (TTM)
$1.09B
Trailing 12 months
Revenue growth YoY
+1.4%
Year over year
Operating margin
9.4%
Trailing 12 months
P / E (TTM)
11.0
Trailing earnings · reciprocal yield 9.1%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.4%
Year over year · more shares
Price change (1Y)
-16.4%
Trailing year
Short interest
0.5%
Latest settlement · 4.7 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Low
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −3%
below
Price vs 50-day avg −5%
below
RSI (14) 42
neutral
MACD trend Positive
52-week position 29%
mid-range
Momentum
relative strength
Very Weak
1-month return −1%
trailing
6-month return −6%
trailing
YTD return −7%
this year
Relative strength −18%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $23 › 200d $23 — 50d above 200d
Institutional flow Distributing
3 of 235 funds reported for Sep 30 · net -3.9K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.52% of float · ▼ -1.2% MoM · 4.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
235 holders — near 3-yr high, broad support
Squeeze score 49
elevated · 0–100
Fundamentals
Strong
Revenue growth +6%
Y/Y
Gross margin 110%
expanding
EPS growth +20%
Y/Y
Free cash flow $1.1B
Balance sheet $7.1B
net debt
Quant / Vol
risk profile
Low
Volatility 29%
annualized · 1-yr
Max drawdown −26%
past year
ATR 1.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−3% Neutral
Price vs 50-day avg
−5% Neutral
RSI (14)
42 Neutral
MACD trend
Positive Bullish
52-week position
29% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $23 › 200d $23 — 50d above 200d
Institutional flow Distributing
3 of 235 funds reported for Sep 30 · net -3.9K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.52% of float · ▼ -1.2% MoM · 4.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
235 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $20 Now $22 · 29% Range high $27
vs 200-day avg -3% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FMS
Fresenius Medical Care AG
this stock
$12.08B -6.6% +5.9% — 0.5%
HCA
HCA Healthcare, Inc.
 $96.64B -8.6% +7.1% 15.0 2.9%
FSNUY
Fresenius SE & Co. KGaA
 $29.92B -13.3% — — 0.0%
THC
Tenet Healthcare Corp
 $20.91B +30.1% +0.9% 10.0 2.5%
EHC
Encompass Health Corp
 $12.18B +12.9% +10.5% 20.1 3.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
236
% held
8.0%
Reported
3 of 235
Top holder
PZENA INVESTMENT MANAGEME…
Held Float
View
Held by Funds
Fund positions
22
View
Short & Settlement
Short Interest Falling
Shares short
2.8M
Days to cover
4.7d
Change
-34.6K sh
View
Short Volume
Short vol %
52%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
1.8K
Value
$39.9K
As of
Sep 9, 2026
View
Off-Exchange
Off-exchange %
32.6%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Jul 10, 2023
View
Financials
Financials
Revenue (FY)
$5.3B
Net income (FY)
$1.2B
EPS diluted
$4.06
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 25, 2026
This year
16
View
Proposed Sales
Value
$119.2K
Shares
5.7K
Filed
Dec 20, 2023
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 3, 2026
Last webcast
Aug 4, 2026
View
Investor Relations
Upcoming events
8
View

Performance

5D 20D 120D MTD YTD
FMS -1.9% -1.0% -6.2% -0.6% -6.6%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -1.7% -0.5% -18.4% -1.5% -19.5%
Key facts CIK 1333141 CUSIP 358029106 13F (30d) 5 filings 5 filers Visit website Investor relations